6.25

3.31% 0.20

Diamedica Therapeutics Inc (DMAC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$6.05

Aprire:

$6.14

Volume 24 ore:

156.55K

Relative Volume:

0.81

Capitalizzazione di mercato:

$336.77M

Reddito:

Utile/perdita netta:

$-32.77M

Rapporto P/E:

-8.9503

EPS:

-0.6983

Flusso di cassa netto:

$-29.56M

1 W Prestazione:

+0.48%

1M Prestazione:

-3.55%

6M Prestazione:

-6.02%

1 anno Prestazione:

+56.25%

Intervallo 1D:

$6.07

$6.37

Intervallo di 1 settimana:

$5.81

$6.44

Portata 52W:

$3.475

$10.42

Diamedica Therapeutics Inc Stock (DMAC) Company Profile

Nome

Diamedica Therapeutics Inc

Settore

Healthcare (1106)

Industria

Biotechnology (615)

Telefono

(763) 496-5454

Indirizzo

301 CARLSON PARKWAY, MINNEAPOLIS, MN

Dipendente

Cinguettio

@diamedica

Prossima data di guadagno

2026-05-06

Ultimi documenti SEC

DMAC's Discussions on Twitter

Compare DMAC vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
DMAC Diamedica Therapeutics Inc	6.25	336.77M	0	-32.77M	-29.56M	-0.6983
VRTX Vertex Pharmaceuticals Inc	424.36	107.87B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	702.27	73.63B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	794.70	49.42B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	301.11	40.20B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	297.49	33.06B	5.36B	287.73M	924.18M	2.5229

Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-11-14	Ripresa	Cantor Fitzgerald	Overweight
2025-10-30	Iniziato	TD Cowen	Buy
2024-10-07	Iniziato	H.C. Wainwright	Buy
2024-04-24	Ripresa	Craig Hallum	Buy
2023-06-22	Aggiornamento	Oppenheimer	Perform → Outperform
2021-04-09	Iniziato	Oppenheimer	Outperform
2021-02-17	Iniziato	ROTH Capital	Buy
2020-10-30	Iniziato	Guggenheim	Buy
2020-07-08	Iniziato	Maxim Group	Buy
2019-04-30	Iniziato	Dougherty & Company	Buy
2019-03-05	Iniziato	Lake Street	Buy

Mostra tutto

Diamedica Therapeutics Inc Borsa (DMAC) Ultime notizie

May 05, 2026

MSN Money - MSN

May 05, 2026

May 04, 2026

DiaMedica Therapeutics Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView

May 04, 2026

May 03, 2026

DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The National Law Review

May 03, 2026

May 02, 2026

DiaMedica Therapeutics (DMAC) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat

May 02, 2026

Apr 30, 2026

DiaMedica Therapeutics to Report First Quarter 2026 Financial Results and Provide a Business Update May 7, 2026 - BioSpace

Apr 30, 2026

Apr 27, 2026

Top Wall Street forecasters revamp DiaMedica Therapeutics expectations ahead of Q4 earnings - MSN

Apr 27, 2026

Apr 24, 2026

DMAC Price Today: DiaMedica Therapeutics Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

Apr 24, 2026

Apr 23, 2026

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Apr 23, 2026

DMAC DiaMedica Therapeutics Inc. reports narrower Q4 2025 loss than consensus forecasts, its stock rises modestly in today’s trading.Expert Market Insights - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 23, 2026

Apr 22, 2026

Is DiaMedica (DMAC) stock worth committing funds to (Drifts Higher) 2026-04-22Community Risk Signals - Cổng thông tin điện tử tỉnh Lào Cai

Apr 22, 2026

Apr 16, 2026

DiaMedica Therapeutics Highlights DM199 Preeclampsia Data, Stroke Interim Catalyst at RedChip Conference - MarketBeat

Apr 16, 2026

Apr 13, 2026

EBITDA per share of DiaMedica Therapeutics Inc. – NASDAQ:DMAC - TradingView

Apr 13, 2026

Is DiaMedica Therapeutics Inc a cyclical or defensive stock2026 Market Sentiment & Precise Swing Trade Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 10, 2026

Returns Recap: How does DiaMedica Therapeutics Inc compare to its peers2026 Geopolitical Influence & Technical Entry and Exit Tips - baoquankhu1.vn

Apr 10, 2026

Apr 07, 2026

RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms - marketscreener.com

Apr 07, 2026

Apr 06, 2026

Should I Buy DiaMedica (DMAC) Stock Today | Price at $6.62, Up 2.16%Community Watchlist - Newser

Apr 06, 2026

Apr 03, 2026

Q1 EPS Estimate for DiaMedica Therapeutics Raised by Analyst - MarketBeat

Apr 03, 2026

What is HC Wainwright’s Forecast for DMAC FY2029 Earnings? - Defense World

Apr 03, 2026

Apr 02, 2026

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Diamedica Therapeutics (DMAC), Elevance Health (ELV) and Oric Pharmaceuticals (ORIC) - The Globe and Mail

Apr 02, 2026

HC Wainwright Issues Pessimistic Estimate for DMAC Earnings - MarketBeat

Apr 02, 2026

Apr 01, 2026

[ARS] DiaMedica Therapeutics Inc. SEC Filing - Stock Titan

Apr 01, 2026

Equity plan expansion at DiaMedica (NASDAQ: DMAC) adds 3.5M shares - Stock Titan

Apr 01, 2026

H.C. Wainwright reiterates DiaMedica stock rating on trial progress By Investing.com - Investing.com India

Apr 01, 2026

H.C. Wainwright reiterates DiaMedica stock rating on trial progress - Investing.com

Apr 01, 2026

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2025 Earnings Call Transcript - Insider Monkey

Apr 01, 2026

Mar 31, 2026

DiaMedica Therapeutics Furnishes 2025 Financial Results and Business Update - The Globe and Mail

Mar 31, 2026

DMAC Should I Buy - Intellectia AI

Mar 31, 2026